NIH Issues New Public Access Policy for NIH-Funded Research
Recently, the National Institutes of Health (NIH) released a new public access policy that accelerates broad access to NIH-funded…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
DOJ Sues CVS, Alleging Violations of the Controlled Substances Act
The United States Department of Justice (DOJ) recently filed a lawsuit against CVS Pharmacy Inc. and various subsidies, alleging…
This Week in Policy and Medicine – February 16, 2025
Welcome to This Week in Policy and Medicine, where we cover key regulatory and policy developments impacting healthcare, life…
Compounder Runs Misleading Super Bowl Ad
Viewers of the Super Bowl may have seen an ad from one of the largest compounders in the United States, Hims & Hers, promoting…
MGMA Asks Congress to Take Action on Medicare Conversion Factor Cut
The Medical Group Management Association (MGMA) recently sent a letter to the119th Congress, demanding immediate action on…
DEA and HHS Extend Telehealth Prescribing Flexibilities
The Drug Enforcement Administration and the HHS are extending flexibilities for providers prescribing controlled substances via…
HHS OIG Report Finds that CMS Made Additional Risk-Adjusted Payments…
A recent OIG report found that diagnoses reported in 2022 Medicare Advantage (MA) encounter data based only on health risk…
NIH Caps Indirect Cost Rates at 15%
In a move that has woken the biomedical research community, the National Institutes of Health (NIH) announced on Friday, February…
CMS is Discontinuing the MA Value-Based Insurance Design Model
The United States Centers for Medicare and Medicaid Services (CMS) recently announced that it will discontinue the Medicare…
This Week in Policy and Medicine – February 9, 2025
Welcome to another edition of "This Week in Policy and Medicine," now available on Spotify and your favorite podcast platform.…